Product Image

Contributor Information

  • Institute Absolute Antibody; University of Oxford

Tool Details

  • Tool name: Anti-CALLA [SS2/36] rAb
  • Clone: SS2/36
  • Tool type: Antibodies
  • Tool sub-type: Primary antibody
  • Class: Recombinant
  • Conjugate: Unconjugated
  • Reactivity: Human
  • Host: Mouse
  • Cancer type: Blood cancer
  • Application: FACS ; IF ; IHC ; IP ; WB
  • Description: CALLA is expressed on B- and T- cell precursors, bone marrow stromal cells, lymphoblastic, Burkitt’s, and follicular germinal center lymphomas, and on cells from patients with chronic myelocytic leukemia (CML). CALLA is a cell surface enzyme that inactivates a variety of peptides. SS2/36 is a marker for Acute Lymphocytic Luekaemia (ALL). CALLA is widely used for identification of "common" type Acute Lymphocytic Leukaemia (ALL).
  • Immunogen: Common acute lymphoblastic leukaemia cells
  • Isotype: IgG1
  • Research area: Cancer; Cell biology; Immunology; Stem cell biology

  • For Research Use Only

Target Details

  • Target: Common Acute Lymphocytic Leukaemia Antigen (CALLA, CD10)
  • Target background: CALLA is expressed on B- and T- cell precursors, bone marrow stromal cells, lymphoblastic, Burkitt's, and follicular germinal center lymphomas, and on cells from patients with chronic myelocytic leukemia (CML). CALLA is a cell surface enzyme that inactivates a variety of peptides. SS2/36 is a marker for Acute Lymphocytic Luekaemia (ALL). CALLA is widely used for identification of "common" type Acute Lymphocytic Leukaemia (ALL).

Application Details

  • Application: FACS ; IF ; IHC ; IP ; WB

Handling

  • Format: Liquid
  • Storage buffer: Unpurified anti-serum from rabbit preserved in 0.02% Thiomersal
  • Shipping conditions: Shipping at 4° C

Documentation

Related Tools

Product Image

Anti-CEACAM20 [1-11A]

#160684
Product Image

Anti-neurones [MH01]

#156614
Product Image

Anti-HRX [HRX107]

#151384

References

  • •  Majdic O, Sugita K, Stockinger H, Skrobal A, Knapp W (1987) Comparative evaluation of CD10 antibodies. In McMichael AJ, et al (eds) Leucocyte Typing III, Oxford University Press, Oxford, New York and Tokyo, p 488-9.